Regina Feederle

Regina Feederle is the Head of the Core Facility Monoclonal Antibodies (CF-MAB) at Helmholtz Munich, supporting researchers in developing customized monoclonal antibodies for therapeutic and biological mechanism studies. She transitioned to this role in 2014 after extensive research in tumor virology and virus-associated cancers.

• Biology studies at Ludwig-Maximilians University, Munich (1990-1995)
• PhD in molecular biology, Institute of Clinical Molecular Biology and Tumor Genetics, GSF, Munich (1997-1999)

Research focus: Her work spans monoclonal antibody development, tumor virology, and molecular biology, with applications in therapeutic approaches and cancer research. She leads a facility offering antibody supply, purification, and sequencing services.